LONDON BROKER RATINGS: Credit Suisse raises boohoo; Peel cuts Genus Read More
AstraZeneca's asthma treatment trials meet primary endpoints Read More
Hutchmed, Astra launch drug combination trial to treat lung cancer Read More
AstraZeneca chief calls for UK to hold off booster jabs for now Read More
UK dividends calendar - next 7 days Read More
Amgen, AstraZeneca new asthma drug gets positive phase three results Read More
LONDON MARKET MIDDAY: Stocks hover amid caution ahead of US jobs data Read More
UPDATE: AstraZeneca and EU reach settlement over vaccine dispute Read More
LONDON MARKET OPEN: Ashmore falls after mixed annual results Read More
AstraZeneca drug Ultomiris approved for use on children in EU Read More
LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC Read More
TOP NEWS: Glaxo and partner start late-stage trial of Covid-19 vaccine Read More
LONDON MARKET MIDDAY: Stocks lower; PureGym continues to mull float Read More
LONDON MARKET OPEN: CRH buoyed by US infrastructure spending bill Read More
TOP NEWS: AstraZeneca's Forxiga treatment wins approval in Japan Read More
Pfizer, Astra jab protection wanes within six months - phone app study Read More
LONDON MARKET MIDDAY: Retailers lead midcaps up but FTSE 100 struggles Read More
TOP NEWS: AstraZeneca sees positive results for Covid-19 treatment Read More
LONDON MARKET PRE-OPEN: Astra works on Covid cocktail; UK sales falter Read More
Pfizer vaccine effectiveness declines faster than AstraZeneca – study Read More
